• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

骨髓瘤诊断间隔的量化:一项系统评价与荟萃分析

Quantifying intervals to diagnosis in myeloma: a systematic review and meta-analysis.

作者信息

Koshiaris Constantinos, Oke Jason, Abel Lucy, Nicholson Brian D, Ramasamy Karthik, Van den Bruel Ann

机构信息

Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.

Department of Haematology, Oxford University Hospitals NHS Trust, Oxford, UK.

出版信息

BMJ Open. 2018 Jun 22;8(6):e019758. doi: 10.1136/bmjopen-2017-019758.

DOI:10.1136/bmjopen-2017-019758
PMID:29934381
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6020959/
Abstract

OBJECTIVES

To quantify the duration of each step of the diagnostic pathway for patients with multiple myeloma from symptom onset to confirmation of diagnosis.

DESIGN

Systematic review and meta-analysis.

DATA SOURCES AND SELECTION CRITERIA

The MEDLINE and Embase databases were searched up until January 2018 to identify articles that reported time intervals from onset of symptoms to diagnosis. Articles focusing on children or adolescents and on the asymptomatic form of the disease (monoclonal gammopathies and smouldering myeloma) were excluded.

DATA COLLECTION AND DATA ANALYSIS

Data were extracted independently by two reviewers. Weighted estimates of the median and IQR were calculated. Risk of bias was assessed using the Aarhus checklist.

MAIN RESULTS

Nine studies were included. The patient interval (first symptom to first presentation) had a median of 26.3 days (IQR: 1-98, n=465, two studies). Subsequently, the primary care interval (first presentation to first referral) was 21.6 days (IQR: 4.6-55.8, n=326, two studies), the diagnostic interval (first presentation to diagnosis) was 108.6 days (IQR: 33.3-241.7, n=5395, seven studies) and the time to diagnosis (first symptom to diagnosis) interval was 163 days (IQR: 84-306, n=341, one study). No studies reported data for the referral to diagnosis interval.

CONCLUSION

The review demonstrates that there is scope for significant reductions in the time to myeloma diagnosis. At present, many patients experience a diagnostic interval longer than 3 months until diagnosis is confirmed.

REVIEW REGISTRATION

Not available. Protocol available in the appendix.

摘要

目的

量化多发性骨髓瘤患者从症状出现到确诊的诊断流程中每个步骤的持续时间。

设计

系统评价和荟萃分析。

数据来源和选择标准

检索MEDLINE和Embase数据库至2018年1月,以识别报告从症状出现到诊断的时间间隔的文章。排除关注儿童或青少年以及疾病无症状形式(单克隆丙种球蛋白病和冒烟型骨髓瘤)的文章。

数据收集和数据分析

由两名审阅者独立提取数据。计算中位数和四分位间距的加权估计值。使用奥胡斯清单评估偏倚风险。

主要结果

纳入9项研究。患者间隔(首次症状到首次就诊)中位数为26.3天(四分位间距:1 - 98,n = 465,两项研究)。随后,初级保健间隔(首次就诊到首次转诊)为21.6天(四分位间距:4.6 - 55.8,n = 326,两项研究),诊断间隔(首次就诊到诊断)为108.6天(四分位间距:33.3 - 241.7,n = 5395,七项研究),诊断时间(首次症状到诊断)间隔为163天(四分位间距:84 - 306,n = 341,一项研究)。没有研究报告转诊到诊断间隔的数据。

结论

该评价表明骨髓瘤诊断时间有显著缩短的空间。目前,许多患者在确诊前经历的诊断间隔超过3个月。

评价注册

不可用。方案见附录。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58af/6020959/55f181176f37/bmjopen-2017-019758f03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58af/6020959/13fc7d66ae88/bmjopen-2017-019758f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58af/6020959/5a98c176d761/bmjopen-2017-019758f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58af/6020959/55f181176f37/bmjopen-2017-019758f03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58af/6020959/13fc7d66ae88/bmjopen-2017-019758f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58af/6020959/5a98c176d761/bmjopen-2017-019758f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58af/6020959/55f181176f37/bmjopen-2017-019758f03.jpg

相似文献

1
Quantifying intervals to diagnosis in myeloma: a systematic review and meta-analysis.骨髓瘤诊断间隔的量化:一项系统评价与荟萃分析
BMJ Open. 2018 Jun 22;8(6):e019758. doi: 10.1136/bmjopen-2017-019758.
2
The patient, diagnostic, and treatment intervals in adult patients with cancer from high- and lower-income countries: A systematic review and meta-analysis.高收入和低收入国家成人癌症患者的患者、诊断和治疗间隔:系统评价和荟萃分析。
PLoS Med. 2022 Oct 20;19(10):e1004110. doi: 10.1371/journal.pmed.1004110. eCollection 2022 Oct.
3
4
Socio-economic inequalities in patient, primary care, referral, diagnostic, and treatment intervals on the lung cancer care pathway: protocol for a systematic review and meta-analysis.肺癌诊疗路径中患者、初级保健、转诊、诊断及治疗间隔方面的社会经济不平等:系统评价与荟萃分析方案
Syst Rev. 2014 Mar 25;3:30. doi: 10.1186/2046-4053-3-30.
5
Quantifying the risk of multiple myeloma from symptoms reported in primary care patients: a large case-control study using electronic records.通过初级保健患者报告的症状量化多发性骨髓瘤的风险:一项使用电子记录的大型病例对照研究。
Br J Gen Pract. 2015 Feb;65(631):e106-13. doi: 10.3399/bjgp15X683545.
6
Lenalidomide plus dexamethasone versus observation in patients with high-risk smouldering multiple myeloma (QuiRedex): long-term follow-up of a randomised, controlled, phase 3 trial.来那度胺联合地塞米松与观察治疗高危冒烟型多发性骨髓瘤患者(QuiRedex):一项随机、对照、3 期临床试验的长期随访。
Lancet Oncol. 2016 Aug;17(8):1127-1136. doi: 10.1016/S1470-2045(16)30124-3. Epub 2016 Jul 9.
7
Atypical antipsychotics for disruptive behaviour disorders in children and youths.用于儿童和青少年破坏性行为障碍的非典型抗精神病药物。
Cochrane Database Syst Rev. 2012 Sep 12(9):CD008559. doi: 10.1002/14651858.CD008559.pub2.
8
Multiple myeloma: causes and consequences of delay in diagnosis.多发性骨髓瘤:诊断延误的原因及后果
QJM. 2007 Oct;100(10):635-40. doi: 10.1093/qjmed/hcm077. Epub 2007 Sep 10.
9
Assessment of time intervals in the pathway to oral cancer diagnosis in north-westerm Spain. Relative contribution of patient interval.西班牙西北部口腔癌诊断流程中的时间间隔评估。患者间隔的相对贡献。
Med Oral Patol Oral Cir Bucal. 2017 Jul 1;22(4):e478-e483. doi: 10.4317/medoral.21676.
10

引用本文的文献

1
Beyond the bone marrow: a review of therapeutic approaches for extramedullary disease in multiple myeloma and the significance of MRD assessment.骨髓之外:多发性骨髓瘤髓外疾病的治疗方法综述及微小残留病评估的意义
J Med Life. 2025 Jun;18(6):536-544. doi: 10.25122/jml-2025-0104.
2
Challenges, Difficulties, and Delayed Diagnosis of Multiple Myeloma.多发性骨髓瘤的挑战、困难及诊断延误
Diagnostics (Basel). 2025 Jul 4;15(13):1708. doi: 10.3390/diagnostics15131708.
3
European Cancer Organisation Essential Requirements for Quality Cancer Care: Hematological malignancies.

本文引用的文献

1
Diagnosing cancer in primary care: results from the National Cancer Diagnosis Audit.初级保健中的癌症诊断:国家癌症诊断审计的结果。
Br J Gen Pract. 2018 Jan;68(666):e63-e72. doi: 10.3399/bjgp17X694169. Epub 2017 Dec 18.
2
Multiple myeloma: routes to diagnosis, clinical characteristics and survival - findings from a UK population-based study.多发性骨髓瘤:诊断途径、临床特征及生存情况——基于英国人群研究的结果
Br J Haematol. 2017 Apr;177(1):67-71. doi: 10.1111/bjh.14513. Epub 2017 Feb 1.
3
Presenting Signs of Multiple Myeloma and the Effect of Diagnostic Delay on the Prognosis.
欧洲癌症组织优质癌症护理基本要求:血液系统恶性肿瘤
Hemasphere. 2025 Mar 31;9(4):e70108. doi: 10.1002/hem3.70108. eCollection 2025 Apr.
4
Disparities in relapsed or refractory multiple myeloma: recommendations from an interprofessional consensus panel.复发性或难治性多发性骨髓瘤的差异:来自跨专业共识小组的建议。
Blood Cancer J. 2024 Aug 27;14(1):149. doi: 10.1038/s41408-024-01129-0.
5
Multiple myeloma: unplanned diagnostic pathways and association with risk factors and survival - a nationwide register-based cohort study in Denmark.多发性骨髓瘤:非计划性诊断途径及其与危险因素和生存的关联 - 丹麦全国基于登记的队列研究。
BMC Cancer. 2024 Aug 12;24(1):998. doi: 10.1186/s12885-024-12706-8.
6
Blood proteins predict the risk of many diseases years before onset.血液蛋白能够在许多疾病发病前数年就预测其风险。
Nat Med. 2024 Sep;30(9):2419-2420. doi: 10.1038/s41591-024-03145-w.
7
Proteomic signatures improve risk prediction for common and rare diseases.蛋白质组学特征可提高常见和罕见疾病的风险预测。
Nat Med. 2024 Sep;30(9):2489-2498. doi: 10.1038/s41591-024-03142-z. Epub 2024 Jul 22.
8
Proactive consultation of laboratory medicine increased diagnostic rate of multiple myeloma: One single center's 12-year experience.主动咨询检验科提高多发性骨髓瘤的诊断率:单中心 12 年经验。
Medicine (Baltimore). 2024 Jun 7;103(23):e38523. doi: 10.1097/MD.0000000000038523.
9
Quantitative risk factor analysis of prior disease condition and socioeconomic status with the multiple myeloma development: nationwide cohort study.定量风险因素分析既往疾病状况和社会经济地位与多发性骨髓瘤发病的关系:全国队列研究。
Sci Rep. 2024 Feb 28;14(1):4885. doi: 10.1038/s41598-024-52720-1.
10
Profile and outcome of multiple myeloma with and without HIV treated at a tertiary hospital in KwaZulu-Natal, South Africa.南非夸祖鲁-纳塔尔省一家三级医院治疗的伴或不伴 HIV 的多发性骨髓瘤患者的特征和转归。
PLoS One. 2023 Oct 25;18(10):e0287304. doi: 10.1371/journal.pone.0287304. eCollection 2023.
多发性骨髓瘤的临床表现及诊断延迟对预后的影响。
J Am Board Fam Med. 2016 Nov 12;29(6):702-709. doi: 10.3122/jabfm.2016.06.150393.
4
Risk factors and time to symptomatic presentation in leukaemia, lymphoma and myeloma.白血病、淋巴瘤和骨髓瘤的危险因素及出现症状的时间
Br J Cancer. 2015 Sep 29;113(7):1114-20. doi: 10.1038/bjc.2015.311. Epub 2015 Sep 1.
5
Age and Gender Variations in Cancer Diagnostic Intervals in 15 Cancers: Analysis of Data from the UK Clinical Practice Research Datalink.15种癌症的癌症诊断间隔中的年龄和性别差异:来自英国临床实践研究数据链的数据分析
PLoS One. 2015 May 15;10(5):e0127717. doi: 10.1371/journal.pone.0127717. eCollection 2015.
6
Diagnostic intervals and its association with breast, prostate, lung and colorectal cancer survival in England: historical cohort study using the Clinical Practice Research Datalink.诊断间隔及其与英格兰乳腺癌、前列腺癌、肺癌和结直肠癌生存率的关联:使用临床实践研究数据链的历史队列研究
PLoS One. 2015 May 1;10(5):e0126608. doi: 10.1371/journal.pone.0126608. eCollection 2015.
7
Is increased time to diagnosis and treatment in symptomatic cancer associated with poorer outcomes? Systematic review.有症状癌症的诊断和治疗时间增加是否与较差的预后相关?系统评价。
Br J Cancer. 2015 Mar 31;112 Suppl 1(Suppl 1):S92-107. doi: 10.1038/bjc.2015.48.
8
The relative length of the patient and the primary care interval in patients with 28 common and rarer cancers.28种常见及罕见癌症患者的患者相对长度及初级保健间隔时间。
Br J Cancer. 2015 Mar 31;112 Suppl 1(Suppl 1):S35-40. doi: 10.1038/bjc.2015.40.
9
Quantifying the risk of multiple myeloma from symptoms reported in primary care patients: a large case-control study using electronic records.通过初级保健患者报告的症状量化多发性骨髓瘤的风险:一项使用电子记录的大型病例对照研究。
Br J Gen Pract. 2015 Feb;65(631):e106-13. doi: 10.3399/bjgp15X683545.
10
Impact of investigations in general practice on timeliness of referral for patients subsequently diagnosed with cancer: analysis of national primary care audit data.全科医疗中的检查对后续被诊断为癌症患者转诊及时性的影响:对全国初级医疗审核数据的分析
Br J Cancer. 2015 Feb 17;112(4):676-87. doi: 10.1038/bjc.2014.634. Epub 2015 Jan 20.